unmc.edu Background and objectives Our purpose was to investigate cardiovascular abnormalities in children with osteogenesis imperfecta (OI). Methods Two hundred children (100 OI, 100 matched ...
Angitia Biopharmaceuticals ("Angitia” or "the Company”), a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases ...
A 10-year-old boy from Leyte who has a genetic disorder called osteogenesis imperfecta received a wheelchair from GMA Kapuso Foundation, according to "24 Oras" on Monday.